Completed PHASE1 INTERVENTIONAL 2-arm NCT01776515

Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients

A Randomized, Double-blind, Active-controlled, Parallel, Multicenter Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients

Sponsor: Daewon Pharmaceutical Co., Ltd.

Conditions Low Back Pain

Interventions Tramadol hydrochloride/Acetaminophen SR Tab. Tramadol hydrochloride/Acetaminophen Tab.

Updated 5 times since 2017 Last updated: Jan 23, 2013 Started: Jan 31, 2012 Primary completion: Mar 31, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01776515, this PHASE1 trial focuses on Low Back Pain and remains completed. Sponsored by Daewon Pharmaceutical Co., Ltd., it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daewon Pharmaceutical Co., Ltd.

Data source: Daewon Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.